The FDA announcement stated that antiviral treatments, including remdesivir, Paxlovid, and Lagevrio, are all still options for patients at high risk for a severe case of COVID-19. Antivirals work “by stopping the coronavirus from replicating in the body,” says a summary from the U.S. Department of Health of Human Services, adding that “this lowers the viral load, reducing the chances of the illness progressing to more serious symptoms and hospitalization.”Source: COVID-19 Monoclonal Antibody Treatments No Longer Effective